7 active trials 5 recruiting 2 Phase 3 1 disease areas 2 changes in 30 days
| Phase 2 | 3 | |
| Phase 3 | 2 | |
| Phase 4 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT05955326 | Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral… | Acute Cerebral Ischemia | Recruiting | 2025-12-31 |
| NCT05956418 | A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock Patients | Hypovolemic Shock | Recruiting | 2025-12-31 |
| Phase 3 | ||||
| NCT05691244 | Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic… | Acute Ischemic Stroke | Recruiting | 2026-09-15 |
| NCT05251181 | A Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative Agent | Hypovolemic Shock | Not Yet Recruiting | 2025-12-30 |
| Phase 2 | ||||
| NCT05514340 | Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy | Hypoxic-Ischemic Encephalopathy | Recruiting | 2025-12-31 |
| NCT04054414 | PMZ-1620 (Sovateltide) in Patients of Acute Spinal Cord Injury | Acute Spinal Cord Injury | Recruiting | 2025-07-04 |
| NCT05241067 | Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in Patients… | Acute Respiratory Distress Syndrome (ARDS) | Not Yet Recruiting | 2026-04-14 |
Stroke (1)